Insulin-like Growth Factor-1, Psoriasis, and Inflammation: A Ménage à Trois?
Psoriatic patients have an accumulation of metabolic syndrome (MS) and cardiovascular diseases (CVD), likely mediated by systemic inflammation, and exhibiting low circulating levels of insulin-like growth factor (IGF)-I, a marker of MS and CVD in the general population. The aim of this study is to d...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2011-09-01
|
Series: | European Journal of Inflammation |
Online Access: | https://doi.org/10.1177/1721727X1100900308 |